Literature DB >> 7483271

Antibody-enhanced binding of dengue-2 virus to human platelets.

S Wang1, R He, J Patarapotikul, B L Innis, R Anderson.   

Abstract

The mechanisms underlying severe thrombocytopenia in dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) are not completely understood. We present here the first evidence that dengue type 2 virus binds to human platelets only in the presence of virus-specific antibody, supporting a role for immune-mediated clearance of platelets in the pathogenesis of thrombocytopenia in DHF/DSS. Antibody-enhanced binding of virus of platelets was also demonstrated with a panel of eight murine monoclonal antibodies specific for the dengue E protein. The degree of binding was dependent on the antibody used but not on the antibody IgG subclass, indicating that factors other than the platelet Fc receptor are involved in binding of virus-antibody complexes to the platelet surface. Confirmation that antibody-dependent virus binding to platelets is not primarily mediated by the platelet Fc receptor was obtained by demonstrating good binding even when platelets were pretreated with the Fc gamma RII-specific antibody IV.3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483271     DOI: 10.1006/viro.1995.1567

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  30 in total

1.  PrM- and cell-binding domains of the dengue virus E protein.

Authors:  S Wang; R He; R Anderson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

2.  Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors.

Authors:  Tzong-Hae Lee; Steven H Kleinman; Li Wen; Lani Montalvo; Deborah S Todd; David J Wright; Leslie H Tobler; Michael P Busch
Journal:  Transfusion       Date:  2011-02-08       Impact factor: 3.157

Review 3.  Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries.

Authors:  Victor J Drew; Lassina Barro; Jerard Seghatchian; Thierry Burnouf
Journal:  Blood Transfus       Date:  2017-04-13       Impact factor: 3.443

4.  Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases.

Authors:  E D Hottz; M F Oliveira; P C G Nunes; R M R Nogueira; R Valls-de-Souza; A T Da Poian; A S Weyrich; G A Zimmerman; P T Bozza; F A Bozza
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

5.  Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing.

Authors:  Natalia Frias-Staheli; Marcus Dorner; Svetlana Marukian; Eva Billerbeck; Rachael N Labitt; Charles M Rice; Alexander Ploss
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

6.  Dengue virus binding and replication by platelets.

Authors:  Ayo Y Simon; Michael R Sutherland; Edward L G Pryzdial
Journal:  Blood       Date:  2015-05-05       Impact factor: 22.113

7.  Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation.

Authors:  Eugenio D Hottz; Juliana F Lopes; Carla Freitas; Rogério Valls-de-Souza; Marcus F Oliveira; Marcelo T Bozza; Andrea T Da Poian; Andrew S Weyrich; Guy A Zimmerman; Fernando A Bozza; Patricia T Bozza
Journal:  Blood       Date:  2013-09-05       Impact factor: 22.113

8.  Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice.

Authors:  Aishwarya Sridharan; Qingfeng Chen; Kin Fai Tang; Eng Eong Ooi; Martin L Hibberd; Jianzhu Chen
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

Review 9.  Dengue viral infections.

Authors:  G N Malavige; S Fernando; D J Fernando; S L Seneviratne
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

10.  Role of CD61+ cells in thrombocytopenia of dengue patients.

Authors:  Sansanee Noisakran; Nattawat Onlamoon; Kovit Pattanapanyasat; Hui-Mien Hsiao; Pucharee Songprakhon; Nasikarn Angkasekwinai; Kulkanya Chokephaibulkit; Francois Villinger; Aftab A Ansari; Guey Chuen Perng
Journal:  Int J Hematol       Date:  2012-09-18       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.